刘秀峰 - AI Profile | 人才画像

基本信息

浏览量：122

职业迁徙

个人简介

擅长恶性肿瘤的内科治疗，尤其是肝胆胰肿瘤的药物治疗以及恶性实体瘤的微创治疗。

研究兴趣

论文共 154 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Immune Checkpoint Inhibitors and Anti-Vascular Endothelial Growth Factor Antibody/tyrosine Kinase Inhibitors with or Without Transarterial Chemoembolization As First-Line Treatment for Advanced Hepatocellular Carcinoma (CHANCE2201): a Target Trial Emulation Study

EClinicalMedicine (2024): 102622-102622

引用20浏览0WOS引用

Chinese Expert Consensus on Refined Diagnosis, Treatment, and Management of Advanced Primary Liver Cancer (2023 Edition)

Xiufeng Liu,Feng Xia,Yue Chen,Huichuan Sun,Zhengqiang Yang, Bo Chen,Ming Zhao,Xinyu Bi,Tao Peng, Aizier Ainiwaer,Zhiwen Luo,Fusheng Wang,Yinying Lu

Liver researchno. 2 (2024): 61-71

引用2浏览0WOS引用

Prognostic nomogram for cholangiocarcinoma after immunotherapy

Chao Chen,Zhan Shi,Xiaoyuan Chu, Hong Liu, Ao Chen,Mingzhen Zhou, Ziyan Zhou,Juan Zhang,Yan Zhao,Jie Shen,Baorui Liu,Xiufeng Liu

crossref（2024）

引用0浏览0引用

Erdafitinib in Asian Patients with Advanced Solid Tumors: an Open-Label, Single-Arm, Phase IIa Trial

Joon Oh Park,Yin-Hsun Feng,Wu-Chou Su,Do-Youn Oh,Bhumsuk Keam,Lin Shen, Sang-We Kim,Xiufeng Liu,Huimin Liao,Min Qing, Chong Zhang, Jiaqi Qian, Xiaodan Tang, Peng Li,Spyros Triantos,Hussein Sweiti

BMC CANCERno. 1 (2024)

引用1浏览0WOS引用

Prognostic Analysis of Systemic Antitumor Therapy in Young Patients with Advanced Liver Cancer: A Cohort Study

Jue Zhang, Chao Chen,Zhaojun Xia, Xi Xiong, Ping Liu, Yanping Xu,Xiufeng Liu,Zixiong Li

Oncology Lettersno. 3 (2024)

引用0浏览0WOS引用

Nomograms Predicting Benefit after Immunotherapy in Oral Bifidobacteria Supplementation ICC Patients: a Retrospective Study

Sihui Zhu,Yuncheng Jin,Juan Zhang, Minzheng Zhou,Baorui Liu,Xiufeng Liu,Jie Shen, Chao Chen

BMC CANCER（2024）

引用0浏览0WOS引用

Chinese Multidisciplinary Expert Consensus on Immune Checkpoint Inhibitor-Based Combination Therapy for Hepatocellular Carcinoma (2023 Edition)

Xiufeng Liu,Yinying Lu,Weiping Zhou,Tao Peng, Jie Zhou,Huaqiang Bi,Feng Xia,Xiaoping Chen

Liver Cancerpp.1-21, (2024)

引用0浏览0WOS引用

The Pattern of Tumor Progression on First-Line Immune Checkpoint Inhibitor-Based Systemic Therapy for Chinese Advanced Hepatocellular Carcinoma –CLEAP 004 Study

Chao-Xu Yang,Yang-Xun Pan,Feng Ye,Xiao-Dong Zhu,Jun Xue, Xi Li,Zhen-Gang Yuan,Lan Zhang,Li Xu,Yong-Jun Chen,Nan-Ya Wang,Hui-Chuan Sun,Xiu-Feng Liu

Frontiers in Immunology（2024）

引用0浏览0WOS引用

Table S3 from Safety, Efficacy, and Biomarker Analysis of Toripalimab in Previously Treated Advanced Melanoma: Results of the POLARIS-01 Multicenter Phase II Trial

Bixia Tang,Zhihong Chi,Yingbo Chen,Xiufeng Liu,Di Wu,Jing Chen,Xin Song, Weifeng Wang,Lihou Dong,Haifeng Song,Hai Wu, Hui Feng,Sheng Yao,Shuikui Qin,Xiaoshi Zhang,Jun Guo

openalex（2023）

引用0浏览0引用

Expanding the Applications of Immune Checkpoint Inhibitors in Advanced Lung Cancer Beyond Disease Progression

Chao Chen, Xi Xiong,Ying Cheng, Haiyun Gen,Wenqiang Zhu, Fei Zhang,Chuandong Zhu,Siqi Han,Xiufeng Liu

FRONTIERS IN IMMUNOLOGY (2023)

引用2浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

Xiufeng Liu(刘秀峰)

副主任医师

论文共 154 篇作者统计合作学者相似作者